Accessibility Menu
Quanterix logo

Quanterix(NASDAQ) QTRX

Market Cap$164.40MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2017)-80%
5 Year-94%
1 Year-46%
1 Month-19%
$3.40
-2.58%
-0.09Today
Quanterix last closing stock price
MetricPriceDate
Last closeUSD 3.492026-07-28
Quanterix stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-12.09%USD 3.972026-07-21
1 month-19.21%USD 4.322026-06-26
3 month+14.43%USD 3.052026-04-29
Year to date-45.13%USD 6.362025-12-31
1 year-46.22%USD 6.492025-07-28
3 year-85.05%USD 23.342023-07-28
5 year-93.52%USD 53.852021-07-29
Since inception-80.02%USD 17.472017-12-07

Quanterix Financials at a Glance

Market Cap

$164.40MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$144.87M

Net Income (TTM)

-$104.19M

EPS (TTM)

-$2.37

P/E Ratio

-1.47

Dividend

$0.00

Beta (Volatility)

1.90 (High)

Price

$3.40

Volume

245,646.558

Open

$3.48

Previous Close

$3.49

Daily Range

$3.38 - $3.57

52-Week Range

$2.40 - $8.77

Estimated Earnings Date

Aug 6, 2026

QTRX News

Person in a lab looking through a microscope

Why Quanterix Stock Bounced Back on Wednesday

Eric VolkmanAug 10, 2022
Medical professionals conferring in a hospial corridor

Why Quanterix Shares Plunged by Nearly 55% Today

Eric VolkmanAug 9, 2022
GettyImages-170086688

Why Shares of Quanterix Are Climbing This Morning

Jason HawthorneOct 12, 2021

QTRX: Motley Fool Moneyball Superscore

54

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Quanterix

Quanterix Corporation focuses on digital biomarker analysis to advance precision health. The company utilizes proprietary technology to enhance biomarker detection sensitivity, aiding early disease diagnosis and optimizing therapy monitoring. Grounded in the rapidly growing field of precision medicine, Quanterix aims to influence diagnostics and tailored treatments through strategic growth and partnerships.

Products and Services

Simoa Technology: An ultra-sensitive biomarker detection platform.

Assay Development: Customization of biomarker assays for various research needs.

Diagnostic Solutions: Tools for disease detection and monitoring at a molecular level.

What Makes Quanterix Corporation Special

Quanterix stands out for its high sensitivity in biomarker detection using Simoa technology. This allows for the identification of low-abundance biomarkers, enabling early diagnosis and personalized healthcare strategies. Such capabilities highlight its competitive edge in precision medicine.

Five Things You Need to Know

Quanterix is a leader in digital biomarker analysis focused on precision health.

Its proprietary Simoa technology enables ultra-sensitive biomarker detection.

Quanterix targets early disease detection and therapy monitoring through its products.

The company seeks to expand its market through strategic partnerships.

Quanterix's innovative approaches are crucial for advancing precision medicine.

AI Generated • Apr 16, 2026

Industry

Life Sciences Tools and Services

Sector

Health Care

Employees

450

CEO

Everett V. Cunningham

Website

www.quanterix.com

Headquarters

Billerica, MA 01821, US

QTRX Financials

Key Financial Metrics (TTM)

Gross Margin

44.13%

Operating Margin

-82.71%

Net Income Margin

-71.92%

Return on Equity

-35.17%

Return on Capital

-32.98%

Return on Assets

-28.41%

Earnings Yield

-68.03%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$164.40MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

47.11M

Volume

245.65K

Avg. Volume

1.13M

Financials (TTM)

Gross Profit

$63.93M

Operating Income

-$119.82M

EBITDA

-$84.67M

Operating Cash Flow

-$81.46M

Capital Expenditure

-$1.44M

Free Cash Flow

-$82.90M

Cash & ST Invst.

$99.27M

Total Debt

$35.34M

Quanterix Performance Analysis

Quanterix annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 105,522,000-4.6%
20232023-12-31USD 122,368,00016.0%
20242024-12-31USD 137,421,00012.3%
20252025-12-31USD 138,897,0001.1%
Quanterix sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-30-19.2%
Q32025-09-3064.2%
Q42025-12-319.2%
Q12026-03-31-17.0%
Quanterix annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -2.6968.0%
20232023-12-31USD -0.75-72.0%
20242024-12-31USD -1.0033.2%
20252025-12-31USD -2.51150.2%
Quanterix sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-30-45.3%
Q32025-09-305.2%
Q42025-12-3132.9%
Q12026-03-3124.5%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$36.42M

+20.3%

Gross Profit

$15.57M

-4.8%

Gross Margin

42.75%

N/A

Market Cap

$164.40MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$365.33K

N/A

Employees

450

N/A

Net Income

-$17.54M

+14.5%

EBITDA

-$11.15M

+47.5%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$99.27M

-62.8%

Total Debt

$35.34M

-2.9%

Accounts Receivable

$26.78M

-5.2%

Inventory

$50.96M

+64.2%

Long Term Debt

$27.40M

-12.9%

Short Term Debt

$7.93M

+60.6%

Return on Assets

-28.41%

N/A

Return on Invested Capital

-37.83%

N/A

Free Cash Flow

-$18.19M

-20.1%

Operating Cash Flow

-$18.11M

-30.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
INGNInogen, Inc.
$6.44+0.31%
IMRXImmuneering Corporation
$4.07-4.13%
CVRXCVRx, Inc.
$4.99+0.81%
SENSSenseonics Holdings, Inc.
$4.91-0.10%

Trending Stocks

Symbol / CompanyPricePrice Chg
SOFISoFi Technologies
$15.58-0.07%
INTCIntel
$85.39-0.01%
NVDANvidia
$193.94-0.02%
FFord Motor Company
$15.56+0.04%

Questions About QTRX

What is the current price of Quanterix?

Quanterix is trading at $3.43 per share.

What is the 52-week range for Quanterix?

Over the past 52 weeks, Quanterix has traded between $2.40 and $8.77.

How much debt does Quanterix have?

As of the most recent reporting period, Quanterix reported total debt of $35.34M.

How much cash does Quanterix have on hand?

Quanterix reported $36.18M in cash and cash equivalents in its most recent financial results.

What is Quanterix’s dividend yield?

Quanterix does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services